Integrase inhibitors

bictegravir

19 February 2018. Related: ARVs, Integrase inhibitors

no separate formulation

Full details about bictegravir

Biktarvy: bictegravir/emtricitabine/TAF

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.

Full details about Biktarvy: bictegravir/emtricitabine/TAF

cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)

1 August 2024. Related: ARVs, Integrase inhibitors, NNRTIs

(not to scale)

Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.

Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)

dolutegravir

30 August 2024. Related: ARVs, Integrase inhibitors

Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.

Full details about dolutegravir

Dovato (dolutegravir + lamivudine)

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)

Full details about Dovato (dolutegravir + lamivudine)

elvitegravir

1 May 2018. Related: ARVs, Integrase inhibitors

Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.

Full details about elvitegravir

Generic ARVs

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs

A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.

Full details about Generic ARVs

Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

12 April 2016. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster

Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

Juluca (dolutegravir + rilpivirine)

12 May 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs

Full details about Juluca (dolutegravir + rilpivirine)

raltegravir

3 January 2022. Related: ARVs, Integrase inhibitors

Once-daily (600mg)          Twice-daily (400 mg)

Full details about raltegravir

Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)

1 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs

Picture not included as there are many different versions.

Full details about TLD or LTD (tenofovir disoproxil, lamivudine, dolutegravir)

Triumeq (dolutegravir + abacavir + 3TC)

30 August 2024. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Triumeq (dolutegravir + abacavir + 3TC)